BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matusiak Ł. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol 2020;183:e171-7. [PMID: 29744872 DOI: 10.1111/bjd.16603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Phan K, Huo YR, Charlton O, Smith SD. Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis. J Cutan Med Surg 2020;24:23-7. [DOI: 10.1177/1203475419874411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 2021:S0190-9622(21)00213-9. [PMID: 33493574 DOI: 10.1016/j.jaad.2021.01.059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Özkur E, Karadağ AS, Üstüner P, Aksoy B, Eşme P, Çalışkan E, Akoğlu G, Kalkan G, Demirseren DD, Polat M, Ozden MG, Kılınç F, Yalçınkaya İyidal A, Kıvanç Altunay İ, Türkmen M, Uğurer E, Baysak S, Fettahlıoğlu Karaman B, Mammadlı K, Baykal Selçuk L, Türkoğlu Z, Atcı T, Didar Balcı D, Adışen E, Temel B, Aktan Ş, Kaçar N, Gündüz K, Türel Ermertcan A, Özdemir M, Ünal Çakıter A, Çölgeçen E, Uçmak D, Kelekçi H, Ataseven A, Durmaz K, Kaya Özden H, Engin B, Yazıcı S, Alpsoy E. Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity. Clin Exp Dermatol 2021;46:532-40. [PMID: 33030217 DOI: 10.1111/ced.14478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chang JE, Choi MS. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. Int J Mol Sci 2020;21:E8960. [PMID: 33255783 DOI: 10.3390/ijms21238960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis. Australas J Dermatol 2020;61:e28-33. [PMID: 31261440 DOI: 10.1111/ajd.13110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee H, Patel K, Singam V, Rastogi S, Silverberg J. Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults. Br J Dermatol 2020;182:327-34. [DOI: 10.1111/bjd.18093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
7 Jalenques I, Ciortianu L, Pereira B, D'incan M, Lauron S, Rondepierre F. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis. Journal of the American Academy of Dermatology 2020;83:542-53. [DOI: 10.1016/j.jaad.2020.03.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
8 Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021;35:50-61. [DOI: 10.1111/jdv.16677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 23.0] [Reference Citation Analysis]